Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.

by Kendall K. Morgan

The rapid development of mRNA COVID-19 vaccines could spark advances in similar treatments for cancer.

by Stephen Ornes

Health care providers and communities are making strides toward ensuring equity in cancer treatment.

by Marci A. Landsmann

A study compares the benefits of fixed doses of immunotherapy compared to weight-based doses, and the Food and Drug Administration approves a targeted therapy for a rare disorder called systemic mastocytosis.

by Bradley Jones

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

by Kevin McLaughlin

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks

Researchers are investigating who is at greatest risk for radiation-induced cancers.

by Kate Yandell

Anti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment, and the FDA approves an immunotherapy drug for endometrial cancer

by Marci A. Landsmann